Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rocket Pharmaceuticals (RCKT) Shares Outstanding (Diluted Average): 2019-2025

Historic Shares Outstanding (Diluted Average) for Rocket Pharmaceuticals (RCKT) over the last 6 years, with Sep 2025 value amounting to $111.6 million.

  • Rocket Pharmaceuticals' Shares Outstanding (Diluted Average) rose 18.49% to $111.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $111.6 million, marking a year-over-year increase of 18.49%. This contributed to the annual value of $94.8 million for FY2024, which is 12.85% up from last year.
  • Latest data reveals that Rocket Pharmaceuticals reported Shares Outstanding (Diluted Average) of $111.6 million as of Q3 2025, which was up 0.50% from $111.0 million recorded in Q2 2025.
  • Over the past 5 years, Rocket Pharmaceuticals' Shares Outstanding (Diluted Average) peaked at $111.6 million during Q3 2025, and registered a low of $61.6 million during Q1 2021.
  • In the last 3 years, Rocket Pharmaceuticals' Shares Outstanding (Diluted Average) had a median value of $93.8 million in 2024 and averaged $94.1 million.
  • Data for Rocket Pharmaceuticals' Shares Outstanding (Diluted Average) shows a peak YoY increased of 24.80% (in 2023) over the last 5 years.
  • Quarterly analysis of 5 years shows Rocket Pharmaceuticals' Shares Outstanding (Diluted Average) stood at $63.2 million in 2021, then climbed by 7.77% to $68.1 million in 2022, then grew by 23.27% to $84.0 million in 2023, then climbed by 12.85% to $94.8 million in 2024, then grew by 18.49% to $111.6 million in 2025.
  • Its Shares Outstanding (Diluted Average) was $111.6 million in Q3 2025, compared to $111.0 million in Q2 2025 and $110.1 million in Q1 2025.